Exact Mass: 525.3488
Exact Mass Matches: 525.3488
Found 173 metabolites which its exact mass value is equals to given mass value 525.3488
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(3R,5R,6S,7S,9R,11E,13R,14S)-14-[(1R)-1-hydroxyethyl]-3,5,7,9,13-pentamethyl-2,4,10-trioxo-1-oxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside
1-Stearoylglycerophosphoserine
1-Stearoylglycerophosphoserine is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PS(18:0/0:0), in particular, consists of two octadecanoyl chains at positions C-1 and C-2. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.
LysoPS(18:0/0:0)
LysoPS(18:0/0:0) is a lysophosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylserines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPS(18:0/0:0), in particular, consists of one chain of stearic acid at the C-1 position.
Ilmofosine
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D000970 - Antineoplastic Agents
Spiropiperidine
tumonoic acid B
A natural product found particularly in Oscillatoria margaritifera and Oscillatoria margaritifera.
neopikromycin
A macrolide antibiotic that is an intermediate in the biosynthesis of pikromycin by Streptomyces venezuelae.
Thr His Ile Arg
C28H47NO8_(3R,5R,6S,7S,9R,11E,13S,14R)-14-Ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-2,4,10-trioxooxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)-D-xylo-hexopyranoside
14-Benzoyltalatizamine
Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Delphinium alkaloid
His Ile Arg Thr
His Ile Thr Arg
His Lys Lys Asn
His Lys Asn Lys
His Leu Arg Thr
His Leu Thr Arg
His Asn Lys Lys
His Arg Ile Thr
His Arg Leu Thr
His Arg Thr Ile
His Arg Thr Leu
His Thr Ile Arg
His Thr Leu Arg
His Thr Arg Ile
His Thr Arg Leu
Ile His Arg Thr
Ile His Thr Arg
Ile Arg His Thr
Ile Arg Thr His
Ile Thr His Arg
Ile Thr Arg His
Lys His Lys Asn
Lys His Asn Lys
Lys Lys His Asn
Lys Lys Asn His
Lys Asn His Lys
Lys Asn Lys His
Leu His Arg Thr
Leu His Thr Arg
Leu Arg His Thr
Leu Arg Thr His
Leu Thr His Arg
Leu Thr Arg His
Asn His Lys Lys
Asn Lys His Lys
Asn Lys Lys His
Arg His Ile Thr
Arg His Leu Thr
Arg His Thr Ile
Arg His Thr Leu
Arg Ile His Thr
Arg Ile Thr His
Arg Leu His Thr
Arg Leu Thr His
Arg Thr His Ile
Arg Thr His Leu
Arg Thr Ile His
Arg Thr Leu His
Thr His Leu Arg
Thr His Arg Ile
Thr His Arg Leu
Thr Ile His Arg
Thr Ile Arg His
Thr Leu His Arg
Thr Leu Arg His
Thr Arg His Ile
Thr Arg His Leu
Thr Arg Ile His
Thr Arg Leu His
(3S,5S)-5-((1S,3S)-1-(BENZYLAMINO)-3-(4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL)-4-METHYLPENTYL)-3-ISOPROPYLDIHYDROFURAN-2(3H)-ONE
Ilmofosine
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D000970 - Antineoplastic Agents